News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Mohamedtaki A. Tejani: A crash course on Bayesian design at ASCOGI25
Jan 27, 2025, 09:39

Mohamedtaki A. Tejani: A crash course on Bayesian design at ASCOGI25

Mohamedtaki A. Tejani, Hematology/Oncology Specialist at Advent Health Medical Group, shared a post on X:

“Namrata Vijayvergia gives us a crash course on Bayesian design as she does the difficult task of giving an engaging discussion on 2 negative studies GI25.”
Mohamedtaki A. Tejani: A crash course on Bayesian design at ASCOGI25

cancer Mohamedtaki A Tejani Namrata Vijayvergia OncoDaily Oncology
Special Coverage
Blog
May 10, 2025, 18:03
April Dorenbosch discussed migrant struggles with cancer care in Europe in Youth Cancer Europe interview
Insight
May 10, 2025, 17:56
David Planchard discussed EGFR-mutated NSCLC and clinical research developments with chinese colleagues
Blog
May 10, 2025, 17:48
Manette Le Grange Highlights ACT for Children Initiative in Pediatric Cancer Care
Blog
May 10, 2025, 17:44
Ashish Shah Explores Viral Mimicry Approach to Glioblastoma at Sylvester Comprehensive Cancer Center
Societies
May 10, 2025, 17:43
LUNGevity Foundation: Upal Basu Roy on progress in Small Cell Lung Cancer research
Science
May 10, 2025, 17:34
Galip Can Uyar: Prediction of 90-day Mortality Among Cancer Patients with Unplanned Hospitalisation
Insight
May 10, 2025, 17:23
Roupen Odabashian reflects on 2025 JAMA study evaluating AI-generated discharge summaries
Drugs
May 10, 2025, 17:11
A*STAR IMCB study led by Valerie Yang identified AZD5153 and Pazopanib drug combination for soft tissue sarcoma treatment
Blog
May 10, 2025, 17:10
Nnamdi Igwe Receives Barry Coller Award for Excellence in Clinical Medicine - Mount Sinai Department of Medicine
Drugs
May 10, 2025, 17:01
FDA approved Bristol Myers Squibb’s Opdivo + Yervoy for first-line treatment of MSI-H/dMMR metastatic colorectal cancer
Blog
May 10, 2025, 16:48
Sylvester Nurses Recount Their Career Paths at the Same Cancer Center - Sylvester Comprehensive Cancer Center
Societies
May 10, 2025, 16:46
European Cancer Organisation announced open submissions for European Cancer Summit 2025 abstracts